Rituximab with plasmapheresis and splenectomy in abo-incompatible liver transplantation.
Monteiro
Iona
I
McLoughlin
Lucille M
LM
Fisher
Adrian
A
de la Torre
Andrew N
AN
Koneru
Baburao
B
D000017:ABO Blood-Group System; D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000276:immunology; D001787:Blood Group Incompatibility; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D017093:Liver Failure / Q000601:surgery*; D016031:Liver Transplantation / Q000276:immunology*; D008212:Lymphocyte Depletion; D008297:Male; D000069283:Rituximab; D013156:Splenectomy; D013997:Time Factors; D016896:Treatment Outcome
D000017:ABO Blood-Group System; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab